Frauke Hautz
Zinzino Independent Partner
¡Bienvenido! Soy su consultor independiente, aquí para guiarlo en su viaje de salud.
Press releases - lunes, 5 de octubre de 2020 15:30 CET
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q3 2020
Strong sales growth during Q3; Zinzino group revenue increased with a total of 49% in Q3 and 49% YTD, compared with the previous year.
The revenue in September for Zinzino's sales markets increased by 64% to SEK 98.1 (60.0) million primarily due to strong growth foremost in Central Europe. Faun Pharma's external sales increased by 32% and amounted to SEK 5.4 (4.1) million. Overall, the Group increased revenues by 61% to SEK 103.5 (64.1) million compared with the previous year.
The third quarter of 2020 became the strongest quarter in the history of the company. The Zinzino based revenue in July - September increased 52% SEK 265.4 (174.9) million compared with previous year. Total group revenue increased 49% to SEK 278,2 (186,5) million.
Accumulated revenue for January – September 2020 increased by 49% SEK 794.6 (534.3) million.
Revenues distributed as follows:
| Regions,MSEK | 20-sep | 19-sep | Change | Q3 2020 | Q3 2019 | Change | YTD 2020 | YTD 2019 | Change |
| Nordic Markets | 34.5 | 28.9 | 19% | 96.6 | 88.3 | 9% | 288.8 | 277.0 | 4% |
| Europe Other Markets | 50.5 | 23.4 | 116% | 137.3 | 65.6 | 109% | 372.1 | 162.3 | 129% |
| Baltic Markets | 5.5 | 4.2 | 31% | 15.4 | 12.3 | 25% | 48.8 | 38.3 | 27% |
| North America | 4.1 | 1.8 | 128% | 10.1 | 5.4 | 87% | 27.0 | 16.1 | 68% |
| Australia | 3.5 | 1.7 | 106% | 6.0 | 3.3 | 81% | 15.7 | 4.8 | 227% |
| Zinzino | 98.1 | 60.0 | 64% | 265.4 | 174.9 | 52% | 752.4 | 498.5 | 51% |
| Faun Pharma | 5.4 | 4.1 | 32% | 12.8 | 11.6 | 10% | 42.2 | 35.8 | 18% |
| Zinzino Group | 103.5 | 64.1 | 61% | 278.2 | 186.5 | 49% | 794.6 | 534.3 | 49% |
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
Marcus Tollbom +46 (0) 70 190 03 12, marcus.tollbom@zinzino.com
Certified Adviser: Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
Zinzino AB (publ) is obliged to publish this information in compliance with current EU regulations governing market abuse. The information was provided by the above contact person for publication at 15:30 the 5th of October 2020.
Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS. Zinzino is based in Gothenburg, with additional offices in Finland, Latvia, Norway, USA, Australia and Hong Kong. Zinzino is a public company and its shares are listed on Nasdaq First North Premier Growth Market.
Compartir esta página
O copiar el link